TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

VACIPLUS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

VACIPLUS

ST13

US500000079341982

Class

5, 9, 10

Filing

79341982

Registration

7357618

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

36

Latest update

11/09/2024

Classification

Registered

Trademark type

Word

Nice classes

5, 9, 10

Filing date

02/09/2022

Registration date

04/16/2024

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/16/2024

Last transaction

04/16/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

26

Owner location

NL

Examiner

STADELI, MARTA

Law office

N50

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Promicol Biotech B.V.

Representatives

Douglas T. Johnson Miller & Martin PLLC

Technical classification

Nice Classes

Class 5Class 9Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Medical reagents for use in rapid clinical, pharmaceutical and diagnostic testing for the analysis and testing of body fluids, namely, for measurement of in vitro coagulation and platelet function in bodily fluids, and for determining the presence of anticoagulants and platelet inhibitors in bodily fluids

Class 9

Computer hardware, namely, desktop computers and handheld computers, detection devices being radiometers and adaptors for computers for connecting to a photometer for luminescence; downloadable and recorded software to be used in the field of rapid clinical and diagnostic testing for measurement of in vitro coagulation and platelet function in bodily fluids, and for determining the presence of anticoagulants and platelet inhibitors in bodily fluids

Class 10

Medical testing apparatus, namely, microplates, cuvettes and disposable cartridges for use in rapid clinical and diagnostic testing for medical purposes, namely, for use in measurement of in vitro coagulation and platelet function in bodily fluids, and for determining the presence of anticoagulants and platelet inhibitors in bodily fluids

Publications

History of USPTO decisions and trademark events.

36 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

11/09/2024

FICS

FINAL DISPOSITION NOTICE SENT TO IB

10/23/2024

FIMP

FINAL DISPOSITION PROCESSED

10/23/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

07/17/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

04/16/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

04/16/2024

GPNX

NOTIFICATION PROCESSED BY IB

01/30/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/30/2024

PUBO

PUBLISHED FOR OPPOSITION

01/30/2024

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

01/10/2024

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

01/10/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/10/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/22/2023

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

12/03/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/16/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/16/2023

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

11/16/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

11/15/2023

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

11/15/2023

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

08/28/2023

GNFR

FINAL REFUSAL E-MAILED

08/28/2023

CNFR

FINAL REFUSAL WRITTEN

08/28/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/25/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/24/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/24/2023

RFNP

REFUSAL PROCESSED BY IB

02/21/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

02/01/2023

RFRR

REFUSAL PROCESSED BY MPU

01/31/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

12/04/2022

CNRT

NON-FINAL ACTION WRITTEN

12/03/2022

DOCK

ASSIGNED TO EXAMINER

11/22/2022

NREP

NEW REPRESENTATIVE AT IB RECEIVED

08/13/2022

MAFR

APPLICATION FILING RECEIPT MAILED

06/18/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/14/2022

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

06/13/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

06/09/2022

Continuous trademark protection

Get notified about every new filing that threatens VACIPLUS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.